O05.1 An analysis of the efficacy of clinically relevant new dual drug combinations for treatment of multi- and extensively-drug resistant neisseria gonorrhoeae. (8th July 2017)
- Record Type:
- Journal Article
- Title:
- O05.1 An analysis of the efficacy of clinically relevant new dual drug combinations for treatment of multi- and extensively-drug resistant neisseria gonorrhoeae. (8th July 2017)
- Main Title:
- O05.1 An analysis of the efficacy of clinically relevant new dual drug combinations for treatment of multi- and extensively-drug resistant neisseria gonorrhoeae
- Authors:
- Singh, V
Bala, M
Bhargava, A
Kakran, M
Bhatnagar, R - Abstract:
- Abstract : Introduction: With the emerging potential crisis of untreatable gonorrhoea CDC and WHO have issued a call for new therapeutics options. Hence, this study was conducted to evaluate the in vitro efficacy of 21 dual antibiotic combinations of currently recommended as well as not in-use antibiotics, for treatment of multidrug resistant (MDR) and extensively drug resistant (XDR) Neisseria gonorrhoeae strains. Methods: Minimum inhibitory concentration (MIC) of 83 n . gonorrhoeae strains including 67 MDR and one XDR strain was determined by Etest for cefixime(IX), ceftriaxone(CRO), spectinomycin (SC), azithromycin (AZ), gentamicin (GM), moxifloxacin (MX) and ertapenem (ETP) alone and as 21 antimicrobial combinations by E-test fixed ratio method. Fractional inhibitory concentration index (FICI) was calculated for each combination and geometric means were determined. A FICI value of:≤0.5, >0.5 to≤1.0, >1.0 to≤4.0 and>4.0 denotes synergistic, additive, indifferent and antagonistic effects respectively. Statistical significance was determined by Mann-Whitney's U -test. Results: The synergy/additive effect without any antagonism was observed in antimicrobial combinations of GM+ETP (34.9%/38.6%), MX+ETP (32.5%/36.2%), AZ+MX (20.5%/25.3%), IX+AZ (9.6%/13.3%) and CRO+AZ (4.8%/30.1%). Geometric mean of FICI for these combinations was 0.57, 0.76, 0.91, 1.0 and 1.15 respectively. Mean MICs of GM+ETP, MX+ETP and AZ+MX was significantly (p value<0.0001) less than that of theAbstract : Introduction: With the emerging potential crisis of untreatable gonorrhoea CDC and WHO have issued a call for new therapeutics options. Hence, this study was conducted to evaluate the in vitro efficacy of 21 dual antibiotic combinations of currently recommended as well as not in-use antibiotics, for treatment of multidrug resistant (MDR) and extensively drug resistant (XDR) Neisseria gonorrhoeae strains. Methods: Minimum inhibitory concentration (MIC) of 83 n . gonorrhoeae strains including 67 MDR and one XDR strain was determined by Etest for cefixime(IX), ceftriaxone(CRO), spectinomycin (SC), azithromycin (AZ), gentamicin (GM), moxifloxacin (MX) and ertapenem (ETP) alone and as 21 antimicrobial combinations by E-test fixed ratio method. Fractional inhibitory concentration index (FICI) was calculated for each combination and geometric means were determined. A FICI value of:≤0.5, >0.5 to≤1.0, >1.0 to≤4.0 and>4.0 denotes synergistic, additive, indifferent and antagonistic effects respectively. Statistical significance was determined by Mann-Whitney's U -test. Results: The synergy/additive effect without any antagonism was observed in antimicrobial combinations of GM+ETP (34.9%/38.6%), MX+ETP (32.5%/36.2%), AZ+MX (20.5%/25.3%), IX+AZ (9.6%/13.3%) and CRO+AZ (4.8%/30.1%). Geometric mean of FICI for these combinations was 0.57, 0.76, 0.91, 1.0 and 1.15 respectively. Mean MICs of GM+ETP, MX+ETP and AZ+MX was significantly (p value<0.0001) less than that of the individual drugs. The combinations of SC+AZ, GM+MX, TX+GM and AZ+GM revealed 14.4%, 9.5%, 7.2% and 7.2% of antagonism with 0%, 8.4%, 15.7%, and 13.3% of synergistic effect respectively. No significant effects were observed with IX+SC, IX+MX, IX+ETP TX+SC, TX+MX, TX+ETP, SC+GM, SC+MX, SC+ETP and AZ+ETP. Conclusion: The study highlights the higher efficacy of GM+ETP, MX+ETP and AZ+MX combinations for MDR and XDR strains than currently recommended CRO+AZ and IX+AZ combinations. In the context of no new classes of antibiotics available, this presents a glimmer of hope to clinical management of the superbug N. gonorrhoeae . … (more)
- Is Part Of:
- Sexually transmitted infections. Volume 93(2017)Supplement 2
- Journal:
- Sexually transmitted infections
- Issue:
- Volume 93(2017)Supplement 2
- Issue Display:
- Volume 93, Issue 2 (2017)
- Year:
- 2017
- Volume:
- 93
- Issue:
- 2
- Issue Sort Value:
- 2017-0093-0002-0000
- Page Start:
- A10
- Page End:
- A10
- Publication Date:
- 2017-07-08
- Subjects:
- Sexually transmitted diseases -- Periodicals
HIV infections -- Periodicals
616.951005 - Journal URLs:
- http://sti.bmj.com/ ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/176/ ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/sextrans-2017-053264.24 ↗
- Languages:
- English
- ISSNs:
- 1368-4973
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18210.xml